Acupuncture for Mild Cognitive Impairment and Dementia: An Overview of Systematic Reviews

Acupuncture represents an ancient therapy with promising potential for the treatment of people with dementia and mild cognitive impairment, according to a broad scientific review published in 2021. The study systematically analyzed all available scientific evidence on the use of acupuncture in these conditions, offering a comprehensive view of its efficacy and limitations.

Mild cognitive impairment is an intermediate condition between normal aging and dementia, characterized by subtle deterioration of memory capacity. Although it does not yet constitute a diagnosis of dementia, approximately one-fifth of cases progress to dementia each year, making this condition a growing concern in our aging population. Dementia, in turn, is a progressive syndrome that profoundly affects cognitive function and becomes increasingly common with global aging. To date, no interventions have been proven to completely cure these conditions, making the search for alternative treatments an urgent need.

Acupuncture arouses special interest because it is a simple, low-cost therapy that may avoid the adverse side effects often associated with conventional medications.

The researchers conducted a systematic review of systematic reviews, which represents the highest possible level of scientific evidence. Chinese and international databases were analyzed through October 2020, including studies that compared acupuncture with Western medications or conventional therapies. The methodology included assessing the methodological quality of the studies through standardized tools and reanalyzing original data from randomized clinical trials. The team extracted information on patient characteristics, types of acupuncture interventions used, control groups, and outcome measures, focusing mainly on clinical effectiveness rate, Mini-Mental State Examination scores, and ability to perform daily activities.

The analysis included 35 systematic reviews published between 2007 and 2020, covering 331 original studies with 22,743 participants. The results demonstrated that acupuncture, including its various modalities such as electroacupuncture, scalp acupuncture, and body acupuncture, proved superior to control treatments. Specifically, the effectiveness rate was significantly higher in groups that received acupuncture compared with conventional medications. On the Mini-Mental State Examination, a sensitive tool for assessing cognitive function, there was a statistically significant improvement in scores of patients treated with acupuncture.

The most frequently used acupuncture points included Baihui, Sishencong, Taichong, and Zusanli, and treatments were administered by specialized medical professionals in a hospital setting. However, when the ability to perform activities of daily living was assessed, acupuncture did not show significant improvement compared with control groups.

For patients, these results suggest that acupuncture may be considered a valid therapeutic alternative when Western medications are contraindicated or when a complementary approach is sought. The improvement in cognitive function, evidenced by standardized tests, may translate into better quality of life and the ability to maintain independence for longer. For healthcare professionals, the findings indicate that acupuncture may be integrated into treatment plans, especially considering its favorable safety profile and low cost. The therapy shows particular promise when applied by qualified acupuncturists, following established protocols and using specific points that have demonstrated efficacy in studies.

However, the study revealed important limitations that should be considered. The methodological quality of most reviews analyzed was classified as critically low, with deficiencies in aspects such as prior registration of research protocols, justifications for study selection, and funding reports. Analysis of evidence quality showed that most results were classified as low or very low quality, mainly due to problems with randomization, allocation concealment, and blinding methods in the original studies. It is important to note that blinding in acupuncture studies presents inherent challenges, since it is difficult to conceal from participants whether they are receiving real acupuncture or placebo.

In addition, possible publication bias was identified, and most studies were conducted in China, limiting the generalizability of results to other populations.

The research concludes that, although acupuncture demonstrates potential as a treatment for mild cognitive impairment and dementia, higher-quality studies are needed to definitively confirm its efficacy. The authors emphasize the need for future research with more rigorous experimental designs, larger samples, and better-defined protocols. For patients interested in this therapy, it is advisable to discuss with qualified healthcare professionals the possibility of including acupuncture as part of a comprehensive treatment plan, always considering current evidence and identified limitations.